Mycoplasma Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Mycoplasma Testing Market is Segmented by Technology (PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies), Product, Application, and Geography.

Market Snapshot

mycoplasma testing market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 13 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The mycoplasma testing market is estimated to register a healthy CAGR over the forecast period. Factors, such as high spending in R&D activities by biopharmaceutical companies, increased government initiatives and funding in research activities, technological advancements, increasing demand for fast, accurate, and affordable testing, and the increasing cell culture contamination, are further driving the market for mycoplasma testing. However, there are certain stringent government regulations across several developed and emerging countries and a high degree of consolidation for new entrants, which are among the major hindrances in the growth of the mycoplasma testing market.

Scope of the Report

The term “mycoplasma” refers to a class of bacteria that is commonly present in cell culture. More correctly known as mollicutes, these bacteria lack a cell wall, making them resistant to commonly used antibiotics, such as penicillin. Mycoplasma is easily spread through droplets during cell culture and can survive in dried form for months. Mycoplasma contamination is difficult to see with a microscope and requires specific testing, to be detected. Contamination can have a profound impact on experimental work. Depending on the species present, mycoplasma organisms can affect cell growth, metabolism, tumourigenicity, and response to chemotherapy.

Kits and Reagents
Enzymatic Methods
DNA Staining
Other Technologies
Cell Line Testing
Bioproduction Testing
Other Applications
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Polymerase Chain Reaction (PCR) Holds Significant Market Share

Polymerase Chain Reaction (PCR) is a technique that is used to amplify target DNA and generate thousands to millions of copies of a particular DNA segment. PCR techniques are used in clinical and research laboratories for a broad variety of applications, which include clinical diagnosis, criminal forensics, and biomedical research. The major factors attributed to the growth of the polymerase chain reaction segment include the increasing application in clinical diagnostics, rising demand for personalized and precision medicine, and technological advancements and applications in drug development. 

For instance, in July 2018, ATCC, the premier global biological materials resource and standards organization and the leading supplier of authenticated cells and advanced cell models, launched its new PCR-based service to detect mycoplasma contamination in cell cultures. ATCC has long recognized the growing challenges among the scientific community for adventitious agent contamination included in cell-based research. Hence, the company introduced this product line to support the authentication of cell lines used in basic and translational research, and it complements the STR profiling service.


North America to Dominate the Market

North America currently dominates the mycoplasma testing market, and it is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, due to its well-established healthcare industry and the rising prevalence of chronic diseases in the region. Other factors driving the growth of this region are the presence of global biotech companies and pharmaceutical players and higher investment in R&D activities in the region. The United States holds the majority of the market share in North America. This is due to the rising healthcare expenditure, along with the rapid adoption of point-of-care testing.


Competitive Landscape

Companies are focusing on various growth strategies, such as new product launches, collaborations, acquisitions, and partnerships, to enhance their market presence. The major players include Abbott, Agilent Technologies, Charles River Laboratories International Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Lonza Group, Merck KGaA, PromoCell GmbH, Sartorius AG, and Thermo Fisher Scientific Inc., among others.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Government Initiatives and Funding in Research Activities

      2. 4.2.2 Increasing Demand for Fast, Accurate, and Affordable Testing

      3. 4.2.3 Increasing Cell Culture Contamination

    3. 4.3 Market Restraints

      1. 4.3.1 Long and Laborious Detection Process

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 Product

      1. 5.1.1 Instruments

      2. 5.1.2 Kits and Reagents

    2. 5.2 Technology

      1. 5.2.1 PCR

      2. 5.2.2 ELISA

      3. 5.2.3 Enzymatic Methods

      4. 5.2.4 DNA Staining

      5. 5.2.5 Other Technologies

    3. 5.3 Application

      1. 5.3.1 Cell Line Testing

      2. 5.3.2 Bioproduction Testing

      3. 5.3.3 Other Applications

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies

      2. 6.1.2 ATCC

      3. 6.1.3 Bionique Testing Laboratories Inc.

      4. 6.1.4 Charles River Laboratories International Inc.

      5. 6.1.5 Eurofins Scientific

      6. 6.1.6 Lonza Group Ltd

      7. 6.1.7 Merck KGaA

      8. 6.1.8 Bionique Testing Laboratories Inc.

      9. 6.1.9 PromoCell GmbH

      10. 6.1.10 Thermo Fisher Scientific Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Mycoplasma Testing Market market is studied from 2018 - 2026.

The Mycoplasma Testing Market is growing at a CAGR of 13% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Bionique Testing Laboratories Inc., Thermo Fisher Scientific Inc., Eurofins Scientific, Merck KGaA, ATCC are the major companies operating in Mycoplasma Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!